News > Nearly a dozen countries resume AstraZeneca shots after EU, UK regulators say benefits outweigh risks

Nearly a dozen countries resume AstraZeneca shots after EU, UK regulators say benefits outweigh risks

20/03/2021 08:36 PM | Click to read full article

Nearly a dozen countries resumed use of AstraZeneca's Covid-19 shots on Friday as EU and British regulators said the benefits outweighed any risks after reports of rare instances of blood clotting that temporarily halted inoculations.

The end of suspensions will kick off a test of public confidence, both in the shot and in drug regulators whose conclusions are under unprecedented scrutiny, as virus variants spread and the global death toll, now at nearly 2.7 million, rises.